ライフサイエンスコーパス: tumor virus

1 tate of a GR-induced promoter (mouse mammary tumor virus).

2 oses additional oncogenic properties of this tumor virus.

3 oma-associated herpesvirus (KSHV) is a human tumor virus.

4 ions by viruses like HIV-1 and mouse mammary tumor virus.

5 uppressor pathway in a manner similar to DNA tumor viruses.

6 so targeted by oncoproteins expressed by DNA tumor viruses.

7 frequent integration sites for mouse mammary tumor viruses.

8 ar stomatitis, pseudocowpox, and Yaba monkey tumor viruses.

9 cts associated with infections with many DNA tumor viruses.

10 mechanisms of transformation employed by DNA tumor viruses.

11 lomaviruses are a family of nonenveloped DNA tumor viruses.

12 through the use of GEM models for human DNA tumor viruses.

13 s, human papillomaviruses, and mouse mammary tumor viruses.

14 red to mediate transformation induced by DNA tumor viruses.

15 in many cancers and is also targeted by DNA tumor viruses.

16 milar to that of T antigens of the small DNA tumor viruses.

17 leosome A of the 3'-LTR of the mouse mammary tumor virus (147 bp MMTV-A).

18 genous superantigen encoded by mouse mammary tumor virus 8 (Mtv-8) by either deletion or T-cell recep

19 radioimmunoconstruct in a transgenic Nestin-tumor virus A (Ntva) mouse model of high-grade glioblast

20 he Keratin 6a (K6a) gene promoter to express tumor virus A (tva), which encodes the receptor for avia

21 ection with EnvA-pseudotyped rabies virus in tumor virus A receptor transgenic mice, indicating that

22 s for two of these viruses-the mouse mammary tumor virus (a retrovirus) and Machupo virus (an arenavi

23 HC-I), C-type lectins, and the mouse mammary tumor virus and herpesvirus saimiri superantigens.

24 ct with the transforming oncoproteins of DNA tumor viruses and this led to rapid advances in our unde

25 s are attractive metabolic targets to combat tumors, virus and parasitic diseases but have not yet be

26 lied to heterogeneous genetic samples (e.g., tumors, viruses, and genomes of organelles).

27 ffective in malignant diseases for which DNA tumor viruses are etiologic agents and that antitumor ac

28 ental effect on viral replication.IMPORTANCE Tumor viruses are known to interact with machinery respo

29 All known DNA tumor viruses are known to target and inactivate two mai

30 Oncoproteins from DNA tumor viruses associate with critical cellular proteins

31 oma-associated herpesvirus (KSHV) is a human tumor virus associated with several cancers.

32 oma-associated herpesvirus (KSHV) is a human tumor virus associated with several cancers.

33 key target of oncoproteins expressed by DNA tumor viruses, but RNA viruses are not known to regulate

34 erse transcriptase in retroviruses (then RNA tumor viruses) by David Baltimore and Howard Temin revol

35 ion and survival in transgenic mouse mammary tumor virus-c-Myc mouse mammary carcinoma cells are both

36 initiated by an overexpressed mouse mammary tumor virus-c-myc transgene, which on its own produced p

37 o the host genome, is a critical step in DNA tumor virus carcinogenesis.

38 Human papillomaviruses (HPV) are small DNA tumor viruses causally associated with cervical cancer.

39 The study of the small DNA tumor viruses continues to provide valuable new insights

40 y, mammary tumors derived from mouse mammary tumor virus-CR-1 mice showed a dramatic reduction of Cav

41 isolated from Cav-1 null(-/-)/mouse mammary tumor virus-CR-1 transgenic animals showed enhanced moti

42 I (TGFbetaRI), either by using mouse mammary tumor virus-Cre mice or by delivering adenoviral vector

43 The mouse mammary tumor virus-Cre-mediated excision of the first coding ex

44 vivo, we created and analyzed murine mammary tumor virus-Cre-mediated FIP200 conditional knock-out (C

45 sively to our understanding of how these DNA tumor viruses directly contribute to human cancers.

46 appears to interact with naked mouse mammary tumor virus DNA somewhat differently than with chromatin

47 Previously, mouse mammary tumor virus-driven polyoma middle T-antigen (MMTV-PyV MT

48 adenomas with lung metastases [mouse mammary tumor virus-driven polyoma virus middle T oncogene (MMTV

49 d 1970s for the discovery of the first human tumor viruses--EBV, hepatitis B virus, and the papilloma

50 Many of the small DNA tumor viruses encode transforming proteins that function

51 antigen, under control of the mouse mammary tumor virus enhancer/promoter, was used to produce mamma

52 Enzootic nasal tumor virus (ENTV) and jaagsiekte sheep retrovirus (JSRV

53 e sheep retrovirus (JSRV) and enzootic nasal tumor virus (ENTV) induce epithelial tumors in the airwa

54 Enzootic nasal tumor virus (ENTV) is related to JSRV but induces tumors

55 e sheep retrovirus (JSRV) and enzootic nasal tumor virus (ENTV), is responsible for their distinct lo

56 ession of latency protein LMP2A by the human tumor virus Epstein-Barr virus (EBV) activates phosphati

57 t virus infection, specifically by the human tumor virus Epstein-Barr virus (EBV) induces a spectrum

58 to harbor exogenous agents such as the human tumor viruses Epstein-Barr virus (EBV) and human papillo

59 The human tumor viruses Epstein-Barr virus (EBV) and Kaposi sarcom

60 Compared with mouse mammary tumor virus-ErbB2 Ink4a/Arf(+/-) mice, mouse mammary tum

61 rus-ErbB2 Ink4a/Arf(+/-) mice, mouse mammary tumor virus-ErbB2 Ink4a/Arf(wt) mammary tumors showed in

62 In mouse mammary tumor virus-erbB2 mice treated with LGD1069, there was a

63 tumorigenic transformation in mouse mammary tumor virus-erbB2 transgenic mice.

64 oma-associated herpesvirus (KSHV) is a human tumor virus expressing latent antigens critical for path

65 ge of 4 months, 100% of female mouse mammary tumor virus-EZH2 virgin mice developed intraductal epith

66 and their application to the study of mouse tumor viruses facilitated the assembly of the first gene

67 Viruses of the DNA tumor virus family share the ability to transform verteb

68 SV40 is a DNA tumor virus found in some studies to be associated at hi

69 rs amenable to analysis is the mouse mammary tumor virus gene regulatory sequence.

70 nt to the entire 3'-end of the mouse mammary tumor virus genome, but further deletions at the 5'- or

71 Evolution of minimal DNA tumor virus' genomes has selected for small viral oncopr

72 Identification of this tumor virus has led to new opportunities for early diagn

73 The study of DNA tumor viruses has been invaluable in uncovering the cell

74 Human papillomavirus type 16 (HPV-16), a DNA tumor virus, has a causal role in cervical cancer, and t

75 The origins of replication of DNA tumor viruses have a highly conserved feature, namely, m

76 Thus, tumor viruses have proved to be invaluable aids in ident

77 Studies of DNA tumor viruses have provided important insights into fund

78 DNA tumor viruses have provided major insights into how canc

79 tumors overexpressing HER2 in mouse mammary tumor virus/HER2 allograft models.

80 ly analyze protein profiles in mouse mammary tumor virus/HER2 transgenic mouse frozen tumor sections

81 gnaling protein, ORF5, of the T-lymphotropic tumor virus herpesvirus saimiri (HVS).

82 This provirus, designated as human mammary tumor virus (HMTV), was 95% homologous to MMTV and revea

83 s for the identification of additional human tumor viruses--human T-cell leukemia virus type 1, hepat

84 Intervention by this DNA tumor virus in cellular translational controls is likely

85 Later identification of mammalian tumor viruses in the 1930s by Richard Shope and John Bit

86 Here, we identify the oncogenes of the DNA tumor viruses, including E7 from human papillomavirus (H

87 Infections with DNA tumor viruses, including members of the polyomavirus fam

88 are rare in mammals; however, several human tumor viruses, including the papillomaviruses and the ga

89 ns of transforming proteins from several DNA tumor viruses, including two papillomaviruses and two po

90 s idea, results with several different human tumor viruses indicate that their oncogenic potential de

91 NK cells against different targets including tumor, virus-infected, and immature dendritic cells.

92 teraction with specific ligands expressed on tumor/virus-infected cells, thus contributing to immune

93 papillomavirus (PV) is a double-stranded DNA tumor virus infecting cervix, mouth, and throat tissues.

94 the IFN pathway in the control of this human tumor virus infection.

95 ypes, including wingless-type murine mammary tumor virus integration site (WNT) pathway subtype, Soni

96 cyclin D1 and wingless-related mouse mammary tumor virus integration site 10b (Wnt10b) in 3T3-L1 cell

97 ome inducible by wingless-type mouse mammary tumor virus integration site family member (WNT)/beta-ca

98 here wnt refers to the wingless-type mammary tumor virus integration site family of proteins), that a

99 ween mesenchymal Wingless-type Mouse Mammary Tumor Virus integration site family, member 10B (Wnt10b)

100 tion of Wingless-related MMTV (mouse mammary tumor virus) integration site 3 (WNT3) by ingrowing axon

101 rphogen Wingless-related MMTV (mouse mammary tumor virus) integration site 3 (WNT3).

102 canonical wingless-type MMTV (mouse mammary tumor virus) integration site family (WNT) signaling pat

103 e best-studied oncoproteins encoded by a DNA tumor virus is adenovirus E1A, which modifies the functi

104 establishment of a latent reservoir by human tumor viruses is a vital step in initiating cellular tra

105 A common feature of human tumor viruses is their ability to stimulate proliferatio

106 sarcoma-associated herpesvirus (KSHV), a DNA tumor virus, is an etiological agent linked to several h

107 rus saimiri (HVS), which is a T-lymphotropic tumor virus, is constitutively targeted to lipid rafts a

108 The DNA tumor virus Kaposi's sarcoma associated herpesvirus (KSH

109 ions, under the control of the mouse mammary tumor virus long terminal repeat promoter, develop multi

110 ary epithelial cells using the mouse mammary tumor virus long terminal repeat.

111 alizing CSF-1R antibody in the mouse mammary tumor virus long-terminal region-driven polyoma middle T

112 3beta under the control of the mouse mammary tumor virus-long terminal repeat develop mammary tumors

113 e whey acidic protein (WAP) or mouse mammary tumor virus-long terminal repeat promoters, develop mamm

114 e steroid responsive MMTV-LTR (mouse mammary tumor virus-long terminal repeat), we show that BRG1 and

115 ositions of nucleosomes on the mouse mammary tumor virus LTR, and additionally, we characterized the

116 In these animals, mouse mammary tumor virus LTR-driven expression of the constitutively

117 , our data provide the first evidence that a tumor virus may use a viral protein to interfere with mi

118 results provide new insights into how human tumor viruses may manipulate cellular DNA-damage respons

119 at the oncoproteins encoded by the small-DNA tumor viruses may use this mechanism to induce c-Myc, wh

120 yk has a positive function in murine mammary tumor virus-mediated tumorigenesis.

121 Two other betaretroviruses, mouse mammary tumor virus (MMTV) and human endogenous retrovirus type

122 APOBEC3 restricts infection by mouse mammary tumor virus (MMTV) and murine leukemia virus (MLV) and t

123 , which control infection with mouse mammary tumor virus (MMTV) and murine leukemia virus (MuLV) via

124 on on two different reporters, mouse mammary tumor virus (MMTV) and prostate-specific antigen (PSA).

125 o 97% nucleotide homology with mouse mammary tumor virus (MMTV) and with retrovirus sequences derived

126 Integration of mouse mammary tumor virus (MMTV) at the common integration site Int6 o

127 l, have suggested that a human mouse mammary tumor virus (MMTV) causes primary biliary cirrhosis (PBC

128 lls stably transfected with an mouse mammary tumor virus (MMTV) chloramphenicol acetyltransferase rep

129 Mouse mammary tumor virus (MMTV) encodes a Rev-like protein, Rem, whic

130 65)b, under the control of the mouse mammary tumor virus (MMTV) enhancer/promoter.

131 cogenic viruses, including the mouse mammary tumor virus (MMTV) envelope (Env).

132 ith sequences derived from the mouse mammary tumor virus (MMTV) envelope glycoprotein, influenza viru

133 The mouse mammary tumor virus (MMTV) Gag protein directs the assembly in t

134 Mouse mammary tumor virus (MMTV) has been classified as a simple retro

135 with sequences similar to the mouse mammary tumor virus (MMTV) has been shown, but convincing eviden

136 3 (mA3) restricts infection by mouse mammary tumor virus (MMTV) in its natural host.

137 s, including HIV in humans and mouse mammary tumor virus (MMTV) in mice.

138 Mouse mammary tumor virus (MMTV) induces breast cancer with almost 100

139 wed that IFN-gamma elicited by mouse mammary tumor virus (MMTV) infection in I/LnJ mice stimulated pr

140 ed that they were resistant to mouse mammary tumor virus (MMTV) infection.

141 Mouse mammary tumor virus (MMTV) is a complex murine retrovirus that e

142 Mouse mammary tumor virus (MMTV) is a complex retrovirus that encodes

143 Mouse mammary tumor virus (MMTV) is a milk-transmitted betaretrovirus

144 Exogenous mouse mammary tumor virus (MMTV) is transmitted via the milk from infe

145 expressing Sim2s driven by the mouse mammary tumor virus (MMTV) long terminal repeat (LTR) promoter w

146 ) protein under control of the mouse mammary tumor virus (MMTV) long terminal repeat promoter.

147 cells under the control of the mouse mammary tumor virus (MMTV) long terminal repeat promoter.

148 oncogene under control of the mouse mammary tumor virus (MMTV) long-terminal repeat (MMT mice).

149 the maximal effect of DEX in a mouse mammary tumor virus (MMTV) luciferase reporter transactivation a

150 otein of the murine retrovirus mouse mammary tumor virus (MMTV) orchestrates the assembly of immature

151 Using the mouse mammary tumor virus (MMTV) promoter as a model, we probed the st

152 in-remodeling complex, and the mouse mammary tumor virus (MMTV) promoter assembled in an array of cor

153 endent transcription from the murine mammary tumor virus (MMTV) promoter by p65 and E1A was investiga

154 ssion under the control of the mouse mammary tumor virus (MMTV) promoter in a transgenic mouse model

155 sponse was investigated on the mouse mammary tumor virus (MMTV) promoter in different chromatin confi

156 ed human SMO (SmoM2) under the mouse mammary tumor virus (MMTV) promoter in transgenic mice leads to

157 Here, the basic features of mouse mammary tumor virus (MMTV) promoter nucleosomal arrays reconstit

158 the interaction of PR with the mouse mammary tumor virus (MMTV) promoter reconstituted into chromatin

159 otein under the control of the mouse mammary tumor virus (MMTV) promoter results in mammary gland hyp

160 We used the mouse mammary tumor virus (MMTV) promoter to target expression of a ki

161 ranscriptional activation of a mouse mammary tumor virus (MMTV) promoter-driven luciferase construct

162 etion of Ppm1d in mice bearing mouse mammary tumor virus (MMTV) promoter-driven oncogenes Erbb2 (also

163 Mouse mammary tumor virus (MMTV) promoter-driven Ptn expressed in MMTV

164 positioned nucleosomes in the mouse mammary tumor virus (MMTV) promoter.

165 t ERalpha under control of the mouse mammary tumor virus (MMTV) promoter.

166 epithelial cells driven by the mouse mammary tumor virus (MMTV) promoter.

167 ene, tva, under control of the mouse mammary tumor virus (MMTV) promoter.

168 orally transmitted retrovirus mouse mammary tumor virus (MMTV) requires the intestinal microbiota fo

169 emogenic virus is a variant of mouse mammary tumor virus (MMTV) that causes thymic lymphomas rather t

170 have shown that CDP represses mouse mammary tumor virus (MMTV) transcription in tissue culture cells

171 The beta retrovirus mouse mammary tumor virus (MMTV) uses transferrin receptor 1 (TfR1) to

172 B leukemogenic virus (TBLV), a mouse mammary tumor virus (MMTV) variant, often induces T-cell leukemi

173 ommon integration site for the mouse mammary tumor virus (MMTV) was identified (designated Int7) in f

174 a transcriptional repressor of mouse mammary tumor virus (MMTV), a betaretrovirus that is a paradigm

175 a, c-myc, and those encoded by mouse mammary tumor virus (MMTV), a glucocorticoid-responsive retrovir

176 shows for the first time that mouse mammary tumor virus (MMTV), a mammalian retrovirus that assemble

177 Mouse mammary tumor virus (MMTV), a well-characterized retrovirus that

178 Many retroviruses, including mouse mammary tumor virus (MMTV), are transmitted most efficiently thr

179 te sheep retrovirus (JSRV) and mouse mammary tumor virus (MMTV), as well as many endogenous retroviru

180 ry-specific deletion inhibited mouse mammary tumor virus (MMTV)- PyMT- and MMTV- Wnt1-driven mammary

181 We intercrossed mouse mammary tumor virus (MMTV)-c-neu transgenic mice with beta3 or b

182 s as judged by findings with a mouse mammary tumor virus (MMTV)-c-rel transgenic mouse model, in whic

183 ammary epithelial cells of the mouse mammary tumor virus (MMTV)-Cre Brca1 conditional exon 11 deletio

184 The mouse mammary tumor virus (MMTV)-Cre-mediated, epithelial-specific abl

185 Mouse mammary tumor virus (MMTV)-ErbB2 mice lacking PKCdelta (deltaKO)

186 of HER2/Neu in breast cancer, mouse mammary tumor virus (MMTV)-Her2/neu transgenic mice that develop

187 2 overexpression, we generated mouse mammary tumor virus (MMTV)-Hoxb7 transgenic mice, and then cross

188 creases mammary cancer risk in mouse mammary tumor virus (MMTV)-infected females even after multiple

189 e previously reported a 660-bp mouse mammary tumor virus (MMTV)-like env gene sequence in approximate

190 The mouse mammary tumor virus (MMTV)-MT model of breast cancer has been im

191 In a mouse mammary tumor virus (MMTV)-MYC transgenic mouse model of breast

192 A total of 50 uniparous mouse mammary tumor virus (MMTV)-neu and 50 nuliparous MMTV-wnt1 trans

193 its the formation of tumors in mouse mammary tumor virus (MMTV)-Neu mice.

194 mor formation in xenograft and mouse mammary tumor virus (MMTV)-neu mouse models in a manner associat

195 PA), inhibits lung metastases in the mammary tumor virus (MMTV)-Neu transgenic mouse breast cancer mo

196 ogenic signaling in the NeuYD [mouse mammary tumor virus (MMTV)-Neu(ndl)-YD5] mammary tumor model.

197 When mouse mammary tumor virus (MMTV)-neu-induced tumor cells were mixed wi

198 st tumorigenesis, we generated mouse mammary tumor virus (MMTV)-NeuNT transgenic mice lacking one or

199 crossing the mutation into the mouse mammary tumor virus (MMTV)-polyoma virus middle T (PyV-mT) trans

200 ation of mammary tumors in the mouse mammary tumor virus (MMTV)-polyoma virus middle T (PyVT) genetic

201 /+) mice were crossed with the mouse mammary tumor virus (MMTV)-Polyoma virus middle T antigen (PyMT)

202 F transcription factors in the mouse mammary tumor virus (MMTV)-polyomavirus middle T oncoprotein (Py

203 tant knock-in (R175H) mice and mouse mammary tumor virus (MMTV)-Wnt-1 transgenic (mWnt-1) mice to spe

204 Here, we have used mouse mammary tumor virus (MMTV)-Wnt1 transgenic mice, which develop s

205 expressed in mammary tumors of mouse mammary tumor virus (MMTV)-Wnt1-transgenic mice and in aggressiv

206 fection with a betaretrovirus, mouse mammary tumor virus (MMTV).

207 ncoded within the env gene of murine mammary tumor virus (MMTV).

208 transcriptional control of the mouse mammary tumor virus (MMTV).

209 lactation and is expressed in mouse mammary tumor virus (MMTV)/PyMT tumors.

210 ted c-neu oncogene driven by a mouse mammary tumor virus (MMTV-neu) in vivo, we show that ErbB2 overe

211 rous, ErbB2/Neu-overexpressing mouse mammary tumor virus (MMTV-Neu) mice have shown that parity induc

212 The absence of endogenous mouse mammary tumor viruses (MMTVs) in the congenic mouse strain, BALB

213 illustrates a distinct mechanism by which a tumor virus modulates vasculature to promote tumorigenes

214 relative to MCC patients with virus-positive tumors, virus-negative MCC patients had significantly in

215 increases NOTCH1 activation in mouse mammary tumor virus-neu mice.

216 celerated tumor progression in mouse mammary tumor virus/neu transgenic mice by inhibiting apoptosis

217 terminal (Cys(2)HisCys) ZBD of Mouse Mammary Tumor Virus nucleocapsid protein (MMTV NCp10) were resis

218 ions in chromosome 22, including the chicken tumor virus number 10 regulator of kinase (Crk)-like (Cr

219 Tumor viruses often target DNA repair machinery to achie

220 Many DNA tumor virus oncogenes are capable of activating and high

221 DNA tumor virus oncoproteins reduce Rb function by either in

222 onal activation from chromatin mouse mammary tumor virus or endogenous promoters in vivo.

223 In cells infected with DNA tumor viruses, p53 is bound to the viral tumor antigens

224 In the mouse mammary tumor virus-Polyoma Middle T (MMTV-PyMT) model of lumina

225 ors have developed, we use the mouse mammary tumor virus-Polyoma Middle T (MMTV-PyMT), which mimics R

226 In mouse mammary tumor virus-polyoma middle T (PyMT) breast cancer mouse

227 ent, we established cohorts of mouse mammary tumor virus-polyoma middle T (PyMT) PAR1(-/-) and PAR2(-

228 l of breast cancer, MMTV-PyMT (mouse mammary tumor virus-polyoma middle T antigen), with Cav-1 (-/-)-

229 east cancer development in the mouse mammary tumor virus-polyoma middle T-antigen model.

230 generated and crossed with the Mouse Mammary Tumor Virus-Polyoma Middle T-Antigen mouse.

231 ls of Kiss1r gene knockout and mouse mammary tumor virus-polyoma virus middle T antigen (MMTV-PyMT)-i

232 itumor response, we engineered mouse mammary tumor virus-polyoma virus middle T antigen mice with end

233 increased pAkt levels in total mouse mammary tumor virus-polyoma virus middle T antigen tumor lysates

234 enesis, we generated wild-type mouse mammary tumor virus/polyoma middle-T (WT/PyMT) and AIB3(+/-)/PyM

235 mice in the background of the mouse mammary tumor virus/polyoma virus middle T oncogene (MMTV-PyMT)

236 d AIB1(-/-) mice harboring the mouse mammary tumor virus-polyomavirus middle T (PyMT) transgene.

237 table (4T1) and autochthonous (mouse mammary tumor virus-polyomavirus middle T Ag (MMTV-PyMT)) mouse

238 br2MGKO mice were mated to the mouse mammary tumor virus-polyomavirus middle T antigen (PyVmT) transg

239 del of luminal breast cancer [murine mammary tumor virus promoter (MMTV-NIC)].

240 2-myristate-13-acetate-induced mouse mammary tumor virus promoter activity and phorbol 12-myristate 1

241 nished activity on the complex mouse mammary tumor virus promoter compared with human GR (hGR).

242 e-dependent PR activation of a mouse mammary tumor virus promoter in both prostate (PC-3) and breast

243 ability to associate with the mouse mammary tumor virus promoter in organized chromatin.

244 MTA1 under the control of the mouse mammary tumor virus promoter long terminal repeat were generated

245 te hSwi-Snf complexes bound to mouse mammary tumor virus promoter nucleosomal arrays, a natural targe

246 lex on individual, single-copy mouse mammary tumor virus promoter nucleosomal arrays.

247 ear factor 1 (NF1) to bind the mouse mammary tumor virus promoter organized as regular chromatin in v

248 epressed the activation of the mouse mammary tumor virus promoter related to overexpression of the tr

249 receptor, to a tandem array of mouse mammary tumor virus promoter sites in live cells, obtaining an e

250 (KDACis) potently repress the mouse mammary tumor virus promoter through transcriptional mechanisms

251 oma middle T antigen under the mouse mammary tumor virus promoter were combined with mice that have d

252 C-->U substitution within the mouse mammary tumor virus promoter, one located within each GRE half-s

253 ncers in mice transgenic for a mouse mammary tumor virus promoter-driven polyomavirus middle T antige

254 A transcriptionally inert Mouse Mammary Tumor Virus promoter-region nucleosome (MMTV-D) has grea

255 gment under the control of the mouse mammary tumor virus promoter.

256 A-isoform interactions at the mouse mammary tumor virus promoter.

257 (T1) under the control of the mouse mammary tumor virus promoter.

258 ion response elements from the mouse mammary tumor virus promoter.

259 (pMT) under the control of the mouse mammary tumor virus promoter.

260 c-fms under the control of the mouse mammary tumor virus promoter.

261 cleosomes (from yeast GAL10 or mouse mammary tumor virus promoters).

262 were performed on a mutant of mouse mammary tumor virus pseudoknot (VPK), for which an NMR structure

263 ity of the folded structure of mouse mammary tumor virus pseudoknot in the presence of different amou

264 ucleotides (ASOs) in the MMTV (mouse mammary tumor virus)-PyMT mouse mammary carcinoma model results

265 In the case of tumor viruses, recent findings suggest that alterations

266 d utilizes a conditional allele of the avian tumor virus receptor A (TVA), which allows infection of

267 It is unclear how DNA tumor viruses regulate these enzymes and how these inter

268 rn based on decades of study on an avian RNA tumor virus, Rous sarcoma virus (RSV).

269 Consequently, human tumor viruses should serve as powerful tools for deciphe

270 ncreasing evidence that the transforming DNA tumor virus simian virus 40 (SV40) is associated with hu

271 DNA tumor viruses such as Kaposi's sarcoma-associated herpes

272 DNA tumor viruses such as simian virus 40 (SV40) express dom

273 are tolerized to an endogenous mouse mammary tumor virus superantigen either by deletion or TCR revis

274 Mouse mammary tumor virus superantigens (vSAGs) are notorious for defy

275 Although the small DNA tumor virus SV40 (simian virus 40) fails to replicate in

276 KS.IMPORTANCE Here we show that HHV-8, a DNA tumor virus that causes Kaposi's sarcoma, infects three

277 Epstein-Barr virus (EBV) is a tumor virus that establishes lifelong infection in most

278 ted herpesvirus (KSHV) is a lymphotropic DNA tumor virus that induces Kaposi's sarcoma and AIDS-relat

279 Adenovirus is a small DNA tumor virus that is a global human pathogen and key biom

280 KSHV is a human tumor virus that maintains its genome as a plasmid in ly

281 ) and Epstein-Barr virus (EBV) are human DNA tumor viruses that express nuclear antigens [latency-ass

282 so through mechanisms distinct from classic tumor viruses that express transforming viral oncoprotei

283 eplication-competent exogenous mouse mammary tumor viruses that failed to induce mammary tumors in su

284 Thus, like many of the small DNA tumor viruses, the first protein expressed upon HCMV inf

285 The mechanism employed by DNA tumor viruses to inhibit p53-dependent transcription fro

286 re micromolar antagonists in a mouse mammary tumor virus transactivation assay.

287 the mid-1970s, the molecular basis by which tumor viruses transform cells into a malignant state was

288 retation of the p53-Tag complexes and of DNA tumor virus transformation in general.

289 also the first demonstration of a human DNA tumor virus upregulating TLR3, a TLR that thus far has b

290 e provided a mechanistic framework for how a tumor virus using the epigenetic machinery can act in a

291 d AIB1(-/-) mice harboring the mouse mammary tumor virus/v-Ha-ras (ras) transgene that induces breast

292 In the middle of the 20th century, animal tumor viruses were heralded as possible models for under

293 uman papillomaviruses (HPVs) are small dsDNA tumor viruses, which are the etiologic agents of most ce

294 the carcinogenic properties of various human tumor viruses, which, in aggregate, are etiologically as

295 gonist of the wingless-related mouse mammary tumor virus (WNT) signaling pathway, is one endometrial

296 B-231 breast cancer cells, and mouse mammary tumor virus-Wnt-1 mammary tumor-derived cells, implicati

297 n in mammary tumors arising in mouse mammary tumor virus-Wnt-1 transgenic mice.

298 ontext of the well-established mouse mammary tumor virus-Wnt-1 transgenic mouse.

299 r efficacy was shown using the mouse mammary tumor virus-Wnt1 tumor model under dosing conditions tha

300 MVMi, MVMc, MVM-G17, tumor virus X (TVX), canine parvovirus (CPV), porcine pa

301 Yaba monkey tumor virus (YMTV) encodes a related family member, 14L,